Repository logo
 

Poly(ADP-ribose) links the DNA damage response to biomineralization

Published version
Peer-reviewed

Type

Article

Change log

Authors

Abstract

Biomineralization of the extracellular matrix is an essential, regulated process. Inappropriate mineralization of bone and the vasculature has devastating effects on patient health, yet an integrated understanding of the chemical and cell biological processes that lead to mineral nucleation remains elusive. Here, we report that biomineralization of bone and the vasculature is associated with extracellular poly(ADP-ribose) synthesized by poly(ADP-ribose) polymerases in response to oxidative and/or DNA damage. We use ultrastructural methods to show poly(ADP-ribose) can form both calcified spherical particles, reminiscent of those found in vascular calcification, and biomimetically calcified collagen fibrils similar to bone. Importantly, inhibition of poly(ADP-ribose) biosynthesis in vitro and in vivo inhibits biomineralization, suggesting a therapeutic route for the treatment of vascular calcifications. We conclude that poly(ADP-ribose) plays a central chemical role in both pathological and physiological extracellular matrix calcification.

Description

Keywords

DNA damage, bone, poly(ADP-ribose), vascular smooth muscle cell, Adolescent, Adult, Aged, Animals, Biomineralization, Blood Vessels, Cattle, Cell Line, Cells, Cultured, Collagen, DNA Damage, Extracellular Matrix, Female, Humans, Male, Mice, Middle Aged, Osteoblasts, Oxidative Stress, Poly Adenosine Diphosphate Ribose, Rats, Rats, Wistar, Sheep, Vascular Calcification

Journal Title

Cell Reports

Conference Name

Journal ISSN

2211-1247
2211-1247

Volume Title

Publisher

Elsevier
Sponsorship
British Heart Foundation (via King's College London) (MKJTSIR)
National Institute for Health Research (NIHR) (unknown)
Medical Research Council (MR/M01066X/1)
Engineering and Physical Sciences Research Council (EP/L027151/1)
Engineering and Physical Sciences Research Council (EP/G037221/1)
British Heart Foundation (None)
Medical Research Council (MR/J007692/1)
Includes BHF and EPSRC funding.